130 related articles for article (PubMed ID: 2692094)
1. Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis.
Lam WK; Chau PY; So SY; Leung YK; Chan JC; Ip M; Sham MK
Respir Med; 1989 Jul; 83(4):299-303. PubMed ID: 2692094
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis.
Lam WK; Chau PY; So SY; Leung YK; Chan JC; Sham MK
Infection; 1986; 14 Suppl 4():S290-2. PubMed ID: 3546147
[TBL] [Abstract][Full Text] [Related]
3. Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong.
Chan TH; Ho SS; Lai CK; Cheung SW; Chan RC; Cheng AF; Chan CH
Chemotherapy; 1996; 42(2):150-6. PubMed ID: 8697891
[TBL] [Abstract][Full Text] [Related]
4. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis.
Currie DC; Garbett ND; Chan KL; Higgs E; Todd H; Chadwick MV; Gaya H; Nunn AJ; Darbyshire JH; Cole PJ
Q J Med; 1990 Aug; 76(280):799-816. PubMed ID: 2217684
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
Rademaker CM; Sips AP; Beumer HM; Hoepelman IM; Overbeek BP; Möllers MJ; Rozenberg-Arska M; Verhoef J
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():75-81. PubMed ID: 2286595
[TBL] [Abstract][Full Text] [Related]
6. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation.
Hill SL; Morrison HM; Burnett D; Stockley RA
Thorax; 1986 Jul; 41(7):559-65. PubMed ID: 3787536
[TBL] [Abstract][Full Text] [Related]
7. Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis.
Law MR; Holt HA; Reeves DS; Hodson ME
J Antimicrob Chemother; 1983 Jan; 11(1):83-8. PubMed ID: 6337988
[TBL] [Abstract][Full Text] [Related]
8. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of ofloxacin and amoxycillin/clavulanate in hospitalized patients with lower respiratory tract infections.
Khajotia R; Drlicek M; Vetter N
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():83-91. PubMed ID: 2286596
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis.
Tsang KW; Chan WM; Ho PL; Chan K; Lam WK; Ip MS
Eur Respir J; 1999 Nov; 14(5):1206-9. PubMed ID: 10596714
[TBL] [Abstract][Full Text] [Related]
11. Sequential therapy with i.v. and oral ofloxacin in lower respiratory tract infections: a comparative study.
Feist H
Infection; 1991; 19 Suppl 7():S380-3. PubMed ID: 1804787
[TBL] [Abstract][Full Text] [Related]
12. Simple method of monitoring colonising microbial load in chronic bronchial sepsis: pilot comparison of reduction in colonising microbial load with antibiotics given intermittently and continuously.
Currie DC; Higgs E; Metcalfe S; Roberts DE; Cole PJ
J Clin Pathol; 1987 Aug; 40(8):830-6. PubMed ID: 3308962
[TBL] [Abstract][Full Text] [Related]
13. The use of probenecid to increase the serum amoxycillin levels in patients with bronchiectasis.
Allen MB; Fitzpatrick RW; Barratt A; Cole RB
Respir Med; 1990 Mar; 84(2):143-6. PubMed ID: 2371437
[TBL] [Abstract][Full Text] [Related]
14. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
15. Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections.
Taskar VS; Sharma RR; Goswami R; John PJ; Mahashur AA
Respir Med; 1992 Mar; 86(2):157-60. PubMed ID: 1615182
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group.
Portier H; May T; Proust A
J Antimicrob Chemother; 1996 May; 37 Suppl A():83-91. PubMed ID: 8737128
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Cranfield R; Breisch S; Pettit R
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
[TBL] [Abstract][Full Text] [Related]
18. Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanate.
Stockley RA; Dragicevic P; Burnett D; Hill SL
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():73-81. PubMed ID: 2606821
[TBL] [Abstract][Full Text] [Related]
19. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
[TBL] [Abstract][Full Text] [Related]
20. A randomized double blind controlled trial comparing two amoxycillin regimens in the treatment of acute exacerbations of chronic bronchitis.
Bennett JB; Crook SJ; Shaw EJ; Davies RJ
J Antimicrob Chemother; 1988 Feb; 21(2):225-32. PubMed ID: 3283093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
